The stalled Dunkirk pharmaceutical project is moving ahead with a new lease for ImmunityBio and tighter controls.
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results